Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Wallensten Medkonsult AB
AB
Active
Org 5569480501
Torstensonsvägen 7 D, 182 66
Djursholm
General medical practice activities
·
NACE 8621
Est. 2013 · 12 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
General medical practice activities
/
Wallensten Medkonsult AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
496
477
546
544
561
Staff expenses
−7
—
—
—
—
EBITDA
457
434
506
518
528
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
457
434
506
518
528
Net financials
62
90
60
1
—
Profit before tax
518
524
565
519
528
Tax
−109
−110
−118
−109
−111
Net profit
409
414
447
410
417
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 297
4 090
3 893
3 643
3 421
Equity
4 156
3 956
3 746
3 494
3 272
Long-term debt
0
0
0
0
0
Short-term debt
142
134
147
149
149
Total debt
142
134
147
149
149
Financial ratios
5-year trend
EBITDA margin
92,1 %
This company
15,8 %
Market median
This company
Market median
483% above market
2021
2025
Equity ratio
96,7 %
This company
38,2 %
Market median
This company
Market median
153% above market
2021
2025
Return on equity
9,8 %
This company
18,4 %
Market median
This company
Market median
47% below market
2021
2025
Net profit margin
82,6 %
This company
8,1 %
Market median
This company
Market median
920% above market
2021
2025
Asset turnover
0,12×
This company
1,12×
Market median
This company
Market median
89% below market
2021
2025
Debt / equity
0,03×
This company
0,62×
Market median
This company
Market median
95% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Wallensten Medkonsult AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
